Treating Myelodysplastic Syndromes Transformation to Acute Myeloid Leukemia

Recording will be available soon.

Target Audience

This activity is intended for hematologist/oncologists, oncology nurses, and other healthcare professionals involved in the care of patients with hematologic malignancies.

Educational Objectives

After completing this activity, the participant should be better able to:

• Provide an overview of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
• Explain the progression from MDS to AML, including the factors that influence the transformation and the clinical implications
• Discuss the diagnostic criteria for distinguishing MDS from AML
• Describe the treatment options and management strategies for both MDS and AML, including emerging therapies
• Review resources and education to support patients, caregivers, and healthcare professionals

Faculty

Aref Al-Kali, MD
Professor of Medicine
MDS Clinic Director
Acute Myeloid Group Chair
Section Head
Division of Hematology
Mayo Clinic 
Rochester, MN 

Jennifer Andres, MSN, RN, FNP-C
Outpatient Hematology Nurse Practitioner
Mayo Clinic
Phoenix, AZ

Continuing Education Information

In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society.  Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Registered Nursing Credit Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.

Method of Participation
There are no fees for participating in or receiving credits for this CE activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

Learners must participate in the entire CE activity, complete, and submit the evaluation form to earn credit. Once submitted, the certificate will be generated. If you have questions regarding the receipt of your certificate, please contact via email at ndane@mlieducation.org.

Providers
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute, Inc.

Supporters
There is no commercial support associated with this CE activity.

For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: profeducation@LLS.org.